Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free Pediatric-Inspired ALL Regimen with Imatinib

Ruiqi Chen, MSc, Xing Liu, PharmD, Solaf Kanfar, MD, Dawn Maze, MDFRCPC,MSc, Steven M Chan, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Karen W.L. Yee, MD, Mark D. Minden, MD PhD, Aaron D Schimmer, MD PhD, Andre C. Schuh, MD, Caroline J McNamara, MBBS, Tracy Murphy, MDFRCP,FRCPath, Anna Xu, Umberto Falcone, MD, Jack Seki, PharmD, Hassan Sibai, MBBS

Blood (2019) 134 (Supplement_1): 1303.

https://doi.org/10.1182/blood-2019-124117

Published: 2019

Journal Articles

Anticoagulation Prophylaxis with Weight-Adjusted Enoxaparin Reduces Rates of Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase-Based Intensification Therapy

Hassan Sibai, MBBS, Ruiqi Chen, Xing Liu, Aaron D Schimmer, MD PhD, Andre Schuh, Arjun Law, MDDM, Caroline J McNamara, MBBS, Dawn Maze, MD FRCPC, MSc, Karen W.L. Yee, MD, Mark D. Minden, MD PhD, Steven M Chan, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Tracy Murphy, MD FRCP, FRCPath, Umberto Falcone, MD, Naoko Sakurai, Joseph M. Brandwein, MD FRCPC, Jack Seki, PharmD

Blood (2018) 132 (Supplement 1): 3974.

https://doi.org/10.1182/blood-2018-99-119984

Published: 2018

Journal Articles

Migration in the Management of Philadelphia Positive ALL: Towards a Lower Risk of VTE

Hassan Sibai, MBBS, Maria Zigas, Arjun Datt Law, MBBS, MD DM, Umberto Falcone, MD, Solaf Sami Kanfar, MD, Naoko Sakurai, Vikas Gupta, MD PhD, Andre Schuh, MD FRCPC, Karen W.L. Yee, MD, Aaron Schimmer, MD PhD, Mark D. Minden, MD PhD, Dawn Maze, MD FRCPC, MSc, Steven M. Chan, MDPhD, Jack Seki, PharmD

Blood (2017) 130 (Supplement 1): 1283.

https://doi.org/10.1182/blood.V130.Suppl_1.1283.1283

Published: 2017

Journal Articles

Failure to Achieve CR with First-Line Treatment Is the Primary Cause of Treatment Failure in T-Cell Lymphoma: The Princess Margaret Cancer Centre Experience

Umberto Falcone, MD PhD, Melania Pintilie, MSc, Ri Wang, Vishal Kukreti, MD, John G. Kuruvilla, MD, Jan M.A. Delabie, MD PhD, Richard Tsang, MD, Michael Crump, MD

Blood (2016) 128 (22): 3005.

https://doi.org/10.1182/blood.V128.22.3005.3005

Published: 2016

Journal Articles

A Retrospective Study of Venous Thromboembolism in Acute Leukemia Patients during Prolonged Hospital Stay. the Princess Margaret Cancer Centre Experience

Hassan Sibai, MD, Umberto Falcone, MD PhD, Arjun Datt Law, MBBS,MDDM, Ali Hosni, MD, Carmen Tan, Naoko Sakurai, Phm, MSc, Andre C. Schuh, MD FRCPC, Mark D. Minden, MD PhD, Steven M. Chan, MD PhD, Karen W.L. Yee, MD, Vikas Gupta, MD FRCP, FRCPath, Aaron D. Schimmer, MD PhD, Jack T Seki, PharmD

Blood (2016) 128 (22): 2615.

https://doi.org/10.1182/blood.V128.22.2615.2615

Published: 2016

Journal Articles

Anticoagulation Prophylaxis in Asparaginase-Based Therapy in Adults with Acute Lymphoblastic Leukemia

Hassan Sibai, MD, Umberto Falcone, MD PhD, Arjun Datt Law, MBBS,MDDM, Naoko Sakurai, Phm, MSc, Lalit Saini, MD, Tian Q Wang, Andrew Stessman, Joseph Samuel, Eshetu G. Atenafu, Ali Hosni, MD, Andre C. Schuh, MD FRCPC, Karen W.L. Yee, MD, Vikas Gupta, MD FRCP, FRCPath, Mark D. Minden, MD PhD, Steven M. Chan, MD PhD, Aaron D. Schimmer, MD PhD, Joseph M. Brandwein, MD FRCPC, Jack T Seki, PharmD

Blood (2016) 128 (22): 1453.

https://doi.org/10.1182/blood.V128.22.1453.1453

Published: 2016

Journal Articles

Preliminary Results of FDG-PET Scanning after GDP Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Relapsed/Refractory (RR) Lymphoma

Matthew D. Cooper, Umberto Falcone, MD PhD, Naom Tau, MD, Eshetu G Atenafu, M.Sc., P.Stat., Richard Tsang, MD, David C. Hodgson, MD, Armand Keating, MD, Ur Metser, MD, Michael Crump, MD, John G. Kuruvilla, MD

Blood (2016) 128 (22): 4645.

https://doi.org/10.1182/blood.V128.22.4645.4645

Published: 2016

Journal Articles

Long-Term Results of Cytarabine-Containing Induction Followed By Consolidation with Autologous Stem Cell Transplant and Rituximab Maintenance As Primary Treatment for Mantle Cell Lymphoma

Umberto Falcone, MD PhD, Shaheena Bashir, Khalil Al-Farsi, MD, Laurie Watkins, C. Denise Turvey, RN, Norman Franke, MD, Armand Keating, MD, Michael Crump, MD, John Kuruvilla, MD

Blood (2015) 126 (23): 1995.

https://doi.org/10.1182/blood.V126.23.1995.1995

Published: 2015

NARROW

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free Pediatric-Inspired ALL Regimen with Imatinib

Anticoagulation Prophylaxis with Weight-Adjusted Enoxaparin Reduces Rates of Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase-Based Intensification Therapy

Migration in the Management of Philadelphia Positive ALL: Towards a Lower Risk of VTE

Failure to Achieve CR with First-Line Treatment Is the Primary Cause of Treatment Failure in T-Cell Lymphoma: The Princess Margaret Cancer Centre Experience

A Retrospective Study of Venous Thromboembolism in Acute Leukemia Patients during Prolonged Hospital Stay. the Princess Margaret Cancer Centre Experience

Anticoagulation Prophylaxis in Asparaginase-Based Therapy in Adults with Acute Lymphoblastic Leukemia

Preliminary Results of FDG-PET Scanning after GDP Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Relapsed/Refractory (RR) Lymphoma

Long-Term Results of Cytarabine-Containing Induction Followed By Consolidation with Autologous Stem Cell Transplant and Rituximab Maintenance As Primary Treatment for Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only